Welip (M) Sdn Bhd · 66-41 · MALAYSIA
For Welip (M) Sdn Bhd · 66-41 · MALAYSIA, import alert is 66-41; import alert name is Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S; country is MALAYSIA; product is Linsen Double Caulis Capsules; product code is 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C; date published is 10/22/2025; address is NO.10, Jalan TTC 26 , Taman Teknologi Cheng , Melaka, Melaka MALAYSIA, verified against its source on 2026-09-16.
- Firm
- Welip (M) Sdn Bhd verified
- Import alert
- 66-41
- Import alert name
- Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S.
- Country
- MALAYSIA verified
- Address
- NO.10, Jalan TTC 26 , Taman Teknologi Cheng , Melaka, Melaka MALAYSIA verified
- Date published
- 10/22/2025 verified
- Product code
- 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. verified
- Product
- Linsen Double Caulis Capsules verified
- FDA notes
- Linsen Double Caulis Capsules is a drug as defined by section 201(g)(1) of the FD&C Act, 21 U.S.C. 321(g)(1), because it is an article intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease and/or intended to affect the structure or function of the body. Statements in product labeling that provide evidence of the intended use of the product include, but may not be limited to, the following: “Traditionally used for relief of backache, lumbago, sinew and cartilage.” verified
What the source says
Welip (M) Sdn Bhd Date Published : 10/22/2025 NO.10, Jalan TTC 26 , Taman Teknologi Cheng , Melaka, Melaka MALAYSIA 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. Date Published: 10/22/2025 Desc: Linsen Double Caulis Capsules Notes: Linsen Double Caulis Capsules is a drug as defined by section 201(g)(1) of the FD&C Act, 21 U.S.C. 321(g)(1), because it is an article intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease and/or intended to affect the structure or function of the body. Statements in product labeling that provide evidence of the intended use of the product include, but may not be limited to, the following: “Traditionally used for relief of backache, lumbago, sinew and cartilage.”
— accessdata.fda.gov, retrieved 2026-09-15
The same source also states
Welip (M) Sdn Bhd Date Published : 12/24/2013 Lot 1892 Riverview Arcade Kuchin , Sarawak, MALAYSIA 66 V - - 99 Miscellaneous Patent Medicines, Etc. Date Published: 12/24/2013 Desc: Ceng Fui Yen 66 V - - 99 Miscellaneous Patent Medicines, Etc. Date Published: 12/24/2013 Desc: Kian Pee Wah
— accessdata.fda.gov, retrieved 2026-09-15
Source
- accessdata.fda.govhttps://www.accessdata.fda.gov/cms_ia/importalert_190.html
This one changes, and we watch it.FDA import alert red lists: firms subject to detention without physical examination is re-read on a schedule and every change is dated. Subscribe: Atom feed · JSON · what has changed so far.